Advertisement
Screener

ARTIVION, INC. (AORT) Cash and Cash Equivalents, Period Increase (Decrease)

2.5 / 5 stars · 59/120 Roast Me

ARTIVION, INC. Cash and Cash Equivalents, Period Increase (Decrease)

ARTIVION, INC. (AORT) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$16.66 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-03-09

  • ARTIVION, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$14.27M, a 668.10% decline year-over-year.
  • ARTIVION, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $1.74M, a 75.89% decline year-over-year.
  • ARTIVION, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$6.38M, a 402.42% decline year-over-year.
  • ARTIVION, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $2.24M, a 69.06% decline year-over-year.
  • ARTIVION, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$16.66M, a 187.46% decline from fiscal 2016.
  • ARTIVION, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $19.05M, a 352.27% increase from fiscal 2015.
  • ARTIVION, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $4.21M.
  • ARTIVION, INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$4.27M, a 117.33% decline from fiscal 2013.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 3 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed
2017-12-31-$14.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
-$12.53M
derived: sum of 2 quarters · filed 2018-03-09
-$18.91M
derived: sum of 3 quarters · filed 2018-03-09
-$16.66M
10-K · filed 2018-03-09
2017-09-30$1.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
-$4.64M
derived: sum of 2 quarters · filed 2017-10-31
-$2.40M
10-Q · filed 2017-10-31
$111.00K
derived: sum of 4 quarters · filed 2018-03-09
2017-06-30-$6.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25
-$4.13M
10-Q · filed 2017-07-25
-$1.62M
derived: sum of 3 quarters · filed 2018-03-09
$5.57M
derived: sum of 4 quarters · filed 2018-03-09
2017-03-31$2.24M
10-Q · filed 2017-04-27
$4.75M
derived: sum of 2 quarters · filed 2018-03-09
$11.95M
derived: sum of 3 quarters · filed 2018-03-09
$14.05M
derived: sum of 4 quarters · filed 2018-03-09
2016-12-31$2.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$9.71M
derived: sum of 2 quarters · filed 2018-03-09
$11.81M
derived: sum of 3 quarters · filed 2018-03-09
$19.05M
10-K · filed 2018-03-09
2016-09-30$7.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$9.30M
derived: sum of 2 quarters · filed 2017-10-31
$16.54M
10-Q · filed 2017-10-31
$15.63M
derived: sum of 4 quarters · filed 2018-03-09
2016-06-30$2.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25
$9.35M
10-Q · filed 2017-07-25
$8.44M
derived: sum of 3 quarters · filed 2018-03-09
$11.86M
derived: sum of 4 quarters · filed 2018-03-09
2016-03-31$7.24M
10-Q · filed 2017-04-27
$6.33M
derived: sum of 2 quarters · filed 2018-03-09
$9.75M
derived: sum of 3 quarters · filed 2018-03-09
$12.41M
derived: sum of 4 quarters · filed 2018-03-09
2015-12-31-$909.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$2.51M
derived: sum of 2 quarters · filed 2018-03-09
$5.17M
derived: sum of 3 quarters · filed 2018-03-09
$4.21M
10-K · filed 2018-03-09
2015-09-30$3.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27
$6.08M
derived: sum of 2 quarters · filed 2016-10-27
$5.12M
10-Q · filed 2016-10-27
$8.67M
derived: sum of 4 quarters · filed 2017-02-16
2015-06-30$2.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-26
$1.70M
10-Q · filed 2016-07-26
$5.25M
derived: sum of 3 quarters · filed 2017-02-16
$4.21M
derived: sum of 4 quarters · filed 2017-02-16
2015-03-31-$962.00K
10-Q · filed 2016-04-29
$2.59M
derived: sum of 2 quarters · filed 2017-02-16
$1.54M
derived: sum of 3 quarters · filed 2017-02-16
-$350.00K
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31$3.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
$2.50M
derived: sum of 2 quarters · filed 2017-02-16
$612.00K
derived: sum of 3 quarters · filed 2017-02-16
-$4.27M
10-K · filed 2017-02-16
2014-09-30-$1.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27
-$2.94M
derived: sum of 2 quarters · filed 2015-10-27
-$7.82M
10-Q · filed 2015-10-27
$12.14M
derived: sum of 4 quarters · filed 2016-02-16
2014-06-30-$1.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28
-$6.77M
10-Q · filed 2015-07-28
$13.19M
derived: sum of 3 quarters · filed 2016-02-16
$19.14M
derived: sum of 4 quarters · filed 2016-02-16
2014-03-31-$4.88M
10-Q · filed 2015-04-29
$15.08M
derived: sum of 2 quarters · filed 2016-02-16
$21.03M
derived: sum of 3 quarters · filed 2016-02-16
$24.13M
derived: sum of 4 quarters · filed 2016-02-16
2013-12-31$19.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16
$25.91M
derived: sum of 2 quarters · filed 2016-02-16
$29.01M
derived: sum of 3 quarters · filed 2016-02-16
$24.63M
10-K · filed 2016-02-16
2013-09-30$5.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28
$9.05M
derived: sum of 2 quarters · filed 2014-10-28
$4.67M
10-Q · filed 2014-10-28
$9.90M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-30$3.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24
-$1.28M
10-Q · filed 2014-07-24
$3.95M
derived: sum of 3 quarters · filed 2015-02-17
$7.74M
derived: sum of 4 quarters · filed 2015-02-17
2013-03-31-$4.38M
10-Q · filed 2014-04-30
-$4.38M
10-Q · filed 2013-04-30
$850.00K
derived: sum of 2 quarters · filed 2015-02-17
$4.64M
derived: sum of 3 quarters · filed 2015-02-17
-$12.52M
derived: sum of 4 quarters · filed 2015-02-17
2012-12-31$5.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
$9.02M
derived: sum of 2 quarters · filed 2015-02-17
-$8.14M
derived: sum of 3 quarters · filed 2015-02-17
-$8.70M
10-K · filed 2015-02-17
-$8.64M
10-K · filed 2013-02-15
2012-09-30$3.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-30
-$13.37M
derived: sum of 2 quarters · filed 2012-10-30
-$13.92M
10-Q · filed 2012-10-30
-$13.30M
derived: sum of 4 quarters · filed 2013-04-30
2012-06-30-$17.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31
-$17.71M
10-Q · filed 2012-07-31
-$17.09M
derived: sum of 3 quarters · filed 2013-04-30
-$15.85M
derived: sum of 4 quarters · filed 2013-04-30
2012-03-31-$551.00K
10-Q · filed 2013-04-30
$74.00K
derived: sum of 2 quarters · filed 2013-04-30
$1.32M
derived: sum of 3 quarters · filed 2013-04-30
-$16.46M
derived: sum of 4 quarters · filed 2013-04-30
2011-12-31$625.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
$1.87M
derived: sum of 2 quarters · filed 2013-02-15
-$15.91M
derived: sum of 3 quarters · filed 2013-02-15
-$13.81M
10-K · filed 2013-02-15
2011-09-30$1.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-30
-$16.53M
derived: sum of 2 quarters · filed 2012-10-30
-$14.44M
10-Q · filed 2012-10-30
-$9.93M
derived: sum of 4 quarters · filed 2013-02-15
2011-06-30-$17.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31
-$15.68M
10-Q · filed 2012-07-31
-$11.17M
derived: sum of 3 quarters · filed 2013-02-15
-$16.31M
derived: sum of 4 quarters · filed 2013-02-15
2011-03-31$2.10M
10-Q · filed 2012-04-26
$6.60M
derived: sum of 2 quarters · filed 2013-02-15
$1.47M
derived: sum of 3 quarters · filed 2013-02-15
2010-12-31$4.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
-$630.00K
derived: sum of 2 quarters · filed 2013-02-15
$5.38M
10-K · filed 2013-02-15
2010-09-30-$5.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27
$875.00K
10-Q · filed 2011-10-27
2010-06-30$6.01M
10-Q · filed 2011-07-29
2009-12-31$12.90M
10-K · filed 2012-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92